TickerKhojComparison · NSE · data 2026-11-02
Acutaas Chemicals Ltd vs GlaxoSmithKline Pharmaceuticals Limited
In plain words
Size: GlaxoSmithKline Pharmaceuticals Limited is about 1.3 times the market value of Acutaas Chemicals Ltd.
Valuation (P/E): Acutaas Chemicals Ltd 74.9 vs GlaxoSmithKline Pharmaceuticals Limited 40.7.
Return on equity: GlaxoSmithKline Pharmaceuticals Limited 49.1% vs Acutaas Chemicals Ltd 24%.
Profit growth over 3 years: Acutaas Chemicals Ltd 62.3% a year vs GlaxoSmithKline Pharmaceuticals Limited 19.3% a year.
Debt to equity: Acutaas Chemicals Ltd 0.02 vs GlaxoSmithKline Pharmaceuticals Limited 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ACUTAAS | GLAXO | |
|---|---|---|
| Price | ₹3,999.2 | ₹2,566.8 |
| Market cap | ₹32,770 cr | ₹42,073 cr |
| P/E | 74.9 | 40.7 |
| P/B | 17.6 | — |
| ROE | 24.0% | 49.1% |
| ROCE | 28.9% | 52.8% |
| Debt / equity | 0.02 | 0.01 |
| Operating margin | 36.5% | 32.8% |
| Dividend yield | 0.06% | 2.30% |
| Sales growth, 3 years (yearly) | 29.5% | 5.5% |
| Profit growth, 3 years (yearly) | 62.3% | 19.3% |
| 1-year return | 134.8% | -2.5% |
| Revenue, last 12 months | ₹1,593 cr | ₹3,955 cr |
| Net profit, last 12 months | ₹439 cr | ₹1,068 cr |
| Latest quarter | Sept 2026 | Jun 2026 |
| Quarter net profit | ₹125 cr | ₹237 cr |
| Quarter profit vs a year earlier | — | +15.7% |
| Promoter holding | 32.66% | 75.00% |
| Health check | Strong (7.5/10) | Strong (7/10) |
Common questions
Which has a higher P/E, Acutaas Chemicals Ltd or GlaxoSmithKline Pharmaceuticals Limited?
Acutaas Chemicals Ltd trades at the higher P/E (74.9 against 40.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
GlaxoSmithKline Pharmaceuticals Limited (49.1% against 24.0%).
Which carries more debt?
Acutaas Chemicals Ltd has the higher debt-to-equity ratio (0.02 against 0.01).